Regenxbio Inc at Credit Suisse Healthcare Conference (Virtual) Transcript
© -
Hey, everybody. Good morning. I'm Marty Auster. I'm one of the Smid Cap Biotech analysts here at Crédit Suisse. Thanks for joining us this morning at the 29th Annual Crédit Suisse Healthcare Conference. I'm pleased to be joined right now by Dr. Steve Pakola, Chief Medical Officer of REGENXBIO, who's going to kind of present REGENX story. Thank you very much for joining us this morning. Steve, good to see you. I'll hand it over to you now.
Hey, Marty, good to see as well this morning. And thanks for the opportunity for us to present. So REGENXBIO, we are a leader in AAV gene therapy treatment. You can advance to our forward-looking statements. So our company, our mission is to improve lives through the curative potential of gene therapy. And we're excited to have the opportunity to do that due to our NAV Technology Platform, which has allowed us to advance into multiple ongoing clinical step
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
